相关实验视频
Updated: Jun 10, 2025
05:34
5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
504
心力衰竭与减少喷射率和慢性病:专注于治疗和干预措施
Hesham Salah Eldin Taha1, Mohamed Momtaz2, Ahmed Adel Elamragy1
1Cardiology Department, Kasr Al-Ainy Faculty of Medicine, Cairo University, Giza, Egypt.
Heart failure reviews
|October 17, 2024
概括
在患有慢性病 (CKD) 的患者中用减少喷射率 (HFrEF) 治疗心力衰竭是具有挑战性的,但可行的. 最近的试验证明了各种治疗方法的安全性和有效性,包括设备干预,用于这个复杂的人群.
科学领域:
- 心脏病学 心脏病学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 临床试验 临床试验
背景情况:
- 降低射出分数 (HFrEF) 的心力衰竭和慢性病 (CKD) 通常并存.
- 这种组合预测了更糟糕的心血管结果,晚期心力衰竭和增加的死亡率.
- 医生经常犹要开处方指南导向的医学疗法,因为担心功能和不良事件.
研究的目的:
- 审查最近的临床试验数据,对HFrEF患有CKD的患者治疗的安全性和有效性.
- 总结主要试验和小规模队列的特点分析后的发现.
- 为这个患者子组提供基于设备的干预和程序的最新信息.
主要方法:
- 最近的临床试验和HFrEF中CKD后期分析的综述.
- 包括小规模队列的数据,评估临终期病 (ESKD) 中的指南导向医学疗法.
- 专注于设备治疗,包括植入式心脏转换器除器,心脏再同步治疗和其他干预措施.
主要成果:
- 最近的试验和分析表明,在患有CKD的HFrEF患者中,已确定的疗法是安全和有效的.
- 准则导向的医学疗法已在末期病 (ESKD) 患者群体中显示出可行性.
- 设备干预,如ICD,CRT和透导管中门修复显示出潜在的好处.
结论:
- 尽管存在挑战和指导方针差距,但证据支持在患有慢性脏病的HFrEF患者中使用各种疗法.
- 基于设备的干预为这个高风险群体提供了有希望的管理策略.
- 为了最佳地管理HFrEF和CKD并发症,需要进一步的研究和指导方针的澄清.
相关概念视频
01:22Heart Failure VI: Adjunct Therapies
5
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
5
01:30Heart Failure V: Medical Management
2
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
2
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
394
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
394
01:22Heart Failure Drugs: Diuretics
346
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
346
01:30Heart Failure V: Nursing Interventions
2
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
2
01:28Chronic Kidney Disease III: Interprofessional Care
2
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
2